Impairment of host defense against disseminated candidiasis in mice overexpressing GATA-3

Infection and Immunity

Volumn 78, Issue 5, 2010, Pages 2302-2311

  Haraguchi, Norihiro ^a   Ishii, Yukio ^a   Morishima, Yuko ^a   Yoh, Keigyou ^a   Matsuno, Yosuke ^a   Kikuchi, Norihiro ^a   Sakamoto, Tohru ^a   Takahashi, Satoru ^a   Hizawa, Nobuyuki ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; RECOMBINANT GAMMA INTERFERON; TRANSCRIPTION FACTOR GATA 3;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; ARTICLE; CONTROLLED STUDY; FUNGUS GROWTH; HOST RESISTANCE; INTERFERON PRODUCTION; INVASIVE CANDIDIASIS; KIDNEY; MACROPHAGE; MOUSE; NONHUMAN; PERITONEAL CAVITY; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; SURVIVAL; TH2 CELL; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; CANDIDA; CANDIDIASIS; CELLS, CULTURED; CYTOKINES; GATA3 TRANSCRIPTION FACTOR; GENE EXPRESSION; INTERFERON-GAMMA; KIDNEY; LEUKOCYTES, MONONUCLEAR; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; SPLEEN; SURVIVAL ANALYSIS;

EID: 77951233576     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01398-09     Document Type: Article

References (40)

1. Abbas, A. K., K. M. Murphy, and A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature 383:787-793.
2. Antachopoulos, C., T. J. Walsh, and E. Roilides. 2007. Fungal infection in primary immunodeficiencies. Eur. J. Pediatr. 166:1099-1117.
3. Ashman, R. B., and J. M. Papadimitriou. 1995. Production and function of cytokines in natural and acquired immunity to Candida albicans infection. Microbiol. Rev. 59:646-672.
4. Ashman, R. B., C. S. Farah, S. Wanasaengsakul, Y. Hu, G. Pang, and R. L. Clancy. 2004. Innate versus adaptive immunity in Candida albicans infection. Immunol. Cell Biol. 82:196-204.
5. Cenci, E., A. Mencacci, G. Del Sero, C. Fe d'Ostiani, P. Mosci, M. Kopf, and L. Romani. 1998. IFN-γ is required for IL-12 responsiveness in mice with Candida albicans infection. J. Immunol. 161:3543-3550.
6. Chessler, A. D., M. Unnikrishnan, A. K. Bei, J. P. Daily, and B. A. Burleigh. 2009. Trypanosoma cruzi triggers an early type I IFN response in vivo at the site of intradermal infection. J. Immunol. 182:2288-2296.
7. Dimopoulos, G., A. Karabinis, G. Samonis, and M. E. Falagas. 2007. Candidemia in immunocompromised and immunocompetent critically ill patients: a prospective comparative study. Eur. J. Clin. Microbiol. Infect. Dis. 26:377-384.
8. Ferber, I. A., H. J. Lee, F. Zonin, V. Heath, A. Mui, N. Arai, and A. O'Garra. 1999. GATA-3 significantly downregulates IFN-γ production from developing Th1 cells in addition to inducing IL-4 and IL-5 levels. Clin. Immunol. 91:134-144.
9. Gozalbo, D., and M. L. Gil. 2009. IFN-gamma in Candida albicans infections. Front. Biosci. 14:1970-1978.
10. Ho, I. C., and L. H. Glimcher. 2002. Transcription: tantalizing time for T cells. Cell 109:S109-S120.
11. Ho, I. C., T. S. Tai, and S. Y. Pai. 2009. GATA3 and the T-cell lineage: essential functions before and after T-helper-2-cell differentiation. Nat. Rev. Immunol. 9:125-135.
12. Kaminuma, O., F. Kitamura, N. Kitamura, M. Miyagishi, K. Taira, K. Yamamoto, O. Miura, and S. Miyatake. 2004. GATA-3 suppresses IFN-γ promoter activity independently of binding to cis-regulatory element. FEBS Lett. 570:63-68. (Pubitemid 38900957)
13. Kaposzta, R., P. Tree, L. Marodi, and S. Gordon. 1998. Characteristic of invasive candidiasis in gamma interferon- and interleukin-4-deficient mice: role of macrophages in host defense against Candida albicans. Infect. Immun. 66:1708-1717.
14. Kobayashi, Y. 2008. The role of chemokines in neutrophil biology. Front. Biosci. 13:2400-2407.
15. Lee, G. R., P. E. Field, and R. A. Flavell. 2001. Regulation of IL-4 gene expression by distal regulatory elements and GATA-3 at the chromatin level. Immunity 14:447-459.
16. Liblau, R. S., S. M. Singer, and H. O. McDevitt. 1995. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 16:34-38.
17. Liew, F. Y., X. Q. Wei, and L. Proudfoot. 1997. Cytokines and nitric oxide as effector molecules against parasitic infections. Philos. Trans. R. Soc. Lond. B Biol. Sci. 352:1311-1315.
18. Louie, A., A. L. Baltch, R. P. Smith, M. A. Franke, W. J. Ritz, J. K. Singh, and M. A. Gordon. 1994. Tumor necrosis factor alpha has a protective role in a murine model of systemic candidiasis. Infect. Immun. 62:2761-2772.
19. Mencacci, A., E. Cenci, G. Del Sero, C. Fe d'Ostiani, C. Montagnoli, and L. Romani. 1999. Innate and adaptive immunity to Candida albicans: a new view of an old paradigm. Rev. Iberoam. Micol. 16:4-7.
20. Mencacci, A., E. Cenci, F. Bistoni, G. Del Sero, A. Bacci, C. Montagnoli, C. Fe d'Ostiani, and L. Romani. 1998. Specific and non-specific immunity to Candida albicans: a lesson from genetically modified animals. Res. Immunol. 149:352-361.
21. Murphy, E., K. Shibuya, N. Hosken, P. Openshaw, V. Maino, K. Davis, K. Murphy, and A. O'Garra. 1996. Reversibility of T helper 1 and 2 populations is lost after long term stimulation. J. Exp. Med. 183:901-913.
22. Ouyang, W., S. H. Ranganath, K. Weindel, D. Bhattacharya, T. L. Murphy, W. C. Sha, and K. M. Murph. 1998. Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity 9:745-755. (Pubitemid 28557602)
23. Pai, S. Y., M. L. Truitt, and I. C. Ho. 2004. GATA-3 deficiency abrogates the development and maintenance of T helper type 2 cells. Proc. Natl. Acad. Sci. U. S. A. 101:1993-1998.
24. Ranganath, S., W. Ouyang, D. Bhattarcharya, W. C. Sha, A. Grupe, G. Peltz, and K. M. Murphy. 1998. GATA-3-dependent enhancer activity in IL-4 gene regulation. J. Immunol. 161:3822-3826. (Pubitemid 28468954)
25. Rangel-Frausto, M. S., T. Wiblin, H. M. Blumberg, L. Saiman, J. Patterson, M. Rinaldi, M. Pfaller, J. E. Edwards, Jr., W. Jarvis, J. Dawson, and R. P. Wenzel. 1999. National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin. Infect. Dis. 29:253-258.
26. + subset expression in murine candidiasis. Th responses correlate directly with genetically determined susceptibility or vaccine- induced resistance. J. Immunol. 150:925-931.
27. Romani, L. 1997. The T cell responses to fungi. Curr. Opin. Immunol. 9:484-490.
28. Romani, L. 1999. Immunity to Candida albicans: Th1, Th2 cells and beyond. Curr. Opin. Microbiol. 2:363-367.
29. Romani, L. 2000. Innate and adaptive immunity in Candida albicans infections and saprophytism. J. Leukoc. Biol. 68:175-179.
30. Rudmann, D. G., A. M. Preston, M. W. Moore, and J. M. Beck. 1998. Susceptibility to Pneumocystis carinii in mice is dependent on simultaneous deletion of IFN-gamma and type 1 and 2 TNF receptor genes. J. Immunol. 161:360-366.
31. Serbina, N. V., T. Jia, T. M. Hohl, and E. G. Pamer. 2008. Monocyte-mediated defense against microbial pathogens. Annu. Rev. Immunol. 26: 421-452.
32. Subauste, C. S., and J. S. Remington. 1991. Role of gamma interferon in Toxoplasma gondii infection. Eur. J. Clin. Microbiol. Infect. Dis. 10:58-67.
33. Takemoto, N., Y. Kamogawa, H. J. Lee, H. Kuruta, K. Arai, A. O'Garra, N. Arai, and S. Miyataka. 2000. Chromatin remodeling at the IL4/IL13 intergenic regulatory region for Th2-specific cytokine gene cluster. J. Immunol. 165:6687-6691. (Pubitemid 32001130)
34. Usui, T., R. Nishikomori, A. Kitani, and W. Strober. 2003. GATA-3 suppresses Th1 development by downregulation of Stat4 and not through effects on IL-12Rbeta2 chain or T-bet. Immunity 18:415-428. (Pubitemid 36351520)
35. Wisplinghoff, H., T. Bischoff, S. M. Tallent, H. Seifert, R. P. Wenzel, and M. B. Edmond. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39:309-317.
36. Yoh, K., K. Shibuya, N. Morito, T. Nakano, K. Ishizaki, H. Shimohata, M. Nose, S. Izui, A. Shibuya, A. Koyama, J. D. Engel, M. Yamamoto, and S. Takahashi. 2003. Transgenic overexpression of GATA-3 in T lymphocytes improved autoimmune glomerulonephritis in mice with a BXSB/Mpj-Yaa genetic background. J. Am. Soc. Nephrol. 14:2494-2502.
37. Zhang, D. H., L. Cohn, P. Ray, K. Bottomly, and A. Ray. 1997. Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J. Biol. Chem. 272:21597-21603.
38. Zhang, D. H., L. Yang, and A. Ray. 1998. Differential responsiveness of the IL-5 and IL-4 genes to transcription factor GATA-3. J. Immunol. 161:3817-3821.
39. Zheng, W. P., and R. A. Flavell. 1997. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89:587-596.
40. Zhumabekov, T., P. Corbella, M. Tolaini, and D. Kioussis. 1995. Improved version of a human CD2 minigene based vector for T cell-specific expression in transgenic mice. J. Immunol. Methods 185:133-140.